Company Directory - Lexicon Pharmaceuticals, Inc.
Company Details - Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc.
WebsiteThe Woodlands, United States
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for human diseases, with a particular emphasis on metabolic disorders.
CCI Score
CCI Score: Lexicon Pharmaceuticals, Inc.
-29.63
0.02%
Latest Event
Mass Layoffs at Lexicon Pharmaceuticals
Lexicon Pharmaceuticals announced a significant restructuring, disbanding its sales team and laying off 60% of its workforce to save $100 million in operating costs, following an FDA letter citing deficiencies in its drug approval application.
Take Action
So what can you do? It's time to make tough choices. Where will you cast your vote?
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
ACCOMPLICE
Lexicon Pharmaceuticals, Inc. is currently rated as an Accomplice.
Latest Events
- NOV222024
Lexicon Pharmaceuticals announced a significant restructuring, disbanding its sales team and laying off 60% of its workforce to save $100 million in operating costs, following an FDA letter citing deficiencies in its drug approval application.
-60
Labor Relations and Human Rights Practices
March 31
The decision to lay off 60% of the workforce and eliminate the sales team represents a significant blow to worker rights and job security. This cost-cutting measure, taken in response to regulatory setbacks, undermines labor relations and reflects an unethical business practice from a workers' rights perspective.
- DEC312020
OpenSecrets' lobbying profile for Lexicon Pharmaceuticals, based on 2020 data, details the company’s engagement in lobbying efforts by retaining multiple lobbying firms to influence federal policy, raising concerns over corporate influence in democratic processes.
-30
Political Contributions and Lobbying Efforts
March 31
The lobbying profile indicates that Lexicon Pharmaceuticals actively engages in lobbying activities. Such involvement is concerning as it may allow the company to exert undue influence on federal policy, potentially prioritizing corporate interests over broad public welfare and democratic accountability. This is viewed unfavorably from an anti-fascist perspective given the risks of corporate political manipulation.
- JAN012020
Lexicon Pharmaceuticals spent $40,000 on lobbying in 2020, as reported by OpenSecrets. This indicates the company's engagement in political contributions and lobbying efforts, reflecting an active role in shaping policy outcomes.
-20
Political Contributions and Lobbying Efforts
March 31
The reported $40,000 lobbying expenditure shows that Lexicon Pharmaceuticals is actively engaging in the political process to influence policy. From a left-leaning, anti-fascist perspective, the use of corporate funds for influencing legislation can undermine democratic accountability, potentially privileging corporate interests over the needs of marginalized communities.
Alternatives
Indianapolis, United States
-35.34
Thousand Oaks, USA
13.63
Kenilworth, United States
12.75
Cambridge, United States
0.27
Pasadena, United States
0.00
North Chicago, United States
-31.53
Cambridge, United States
-33.87
Menlo Park, United States
-49.80
Bagsværd, Denmark
18.81
Foster City, USA
1.64
Industries
- 325412
- Pharmaceutical Preparation Manufacturing
- 541714
- Research and Development in Biotechnology (except Nanobiotechnology)
- 541715
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)